Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang-Yu Liu

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Cancer Medicine|November 28, 2018
Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancerNai-Si Huang, Xing-Xing Chen, Wen-Jun Wei, et al.
Journal of the National Cancer Institute|November 5, 2020
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast CancerDing Ma, Si-Yu Chen, Jin-Xiao Ren, et al.
Breast Cancer Research : BCR|March 16, 2016
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancerYi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.
Cancer|March 21, 2019
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trialKe-Da Yu, Si-Yu Wu, Guang-Yu Liu, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Springerplus|August 21, 2013
Performance of breast cancer screening methods and modality among Chinese women: a report from a society-based breast screening program (SBSP) in ShanghaiMiao Mo, Guang-Yu Liu, Ying Zheng, et al.
Cancer Letters|April 13, 2026
Integrated Genomic Profiling Identifies Predictive Biomarkers for Neoadjuvant Therapy Response in Chinese Breast Cancer PatientsXiao-Han Ying, Kun-Yu Zhang, Shu-Hao Jiang, et al.
BMJ (Clinical Research Ed.)|December 23, 2025
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trialYin Liu, Yue Gong, Xiu-Zhi Zhu, et al.
Cell Research|March 27, 2023
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trialYin Liu, Xiu-Zhi Zhu, Yi Xiao, et al.
JAMA Oncology|August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialKe-Da Yu, Fu-Gui Ye, Min He, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Cancer Medicine|November 28, 2018
Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancerNai-Si Huang, Xing-Xing Chen, Wen-Jun Wei, et al.
Journal of the National Cancer Institute|November 5, 2020
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast CancerDing Ma, Si-Yu Chen, Jin-Xiao Ren, et al.
Breast Cancer Research : BCR|March 16, 2016
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancerYi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.
Cancer|March 21, 2019
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trialKe-Da Yu, Si-Yu Wu, Guang-Yu Liu, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Springerplus|August 21, 2013
Performance of breast cancer screening methods and modality among Chinese women: a report from a society-based breast screening program (SBSP) in ShanghaiMiao Mo, Guang-Yu Liu, Ying Zheng, et al.
Cancer Letters|April 13, 2026
Integrated Genomic Profiling Identifies Predictive Biomarkers for Neoadjuvant Therapy Response in Chinese Breast Cancer PatientsXiao-Han Ying, Kun-Yu Zhang, Shu-Hao Jiang, et al.
BMJ (Clinical Research Ed.)|December 23, 2025
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trialYin Liu, Yue Gong, Xiu-Zhi Zhu, et al.
Cell Research|March 27, 2023
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trialYin Liu, Xiu-Zhi Zhu, Yi Xiao, et al.
JAMA Oncology|August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialKe-Da Yu, Fu-Gui Ye, Min He, et al.
Pageof 12